NR4A1 and obesity due to melanocortin 4 receptor deficiency: Furthermore, recent studies have reported a significant association between obesity and poorer prognosis in hormone receptor-positive breast cancer (5, 6), and adjuvant hormone therapy, which is commonly used in hormone receptor-positive early disease, can cause side effects such as weight gain (7).